Mar 05, 2024

Can’t-miss Industry Product Theater sessions

Gain additional educational and product-oriented knowledge.

large audience in AAD Industry Product Theater

See what’s new with industry during these educational and product-oriented sessions taking place during the 2024 AAD Annual Meeting. These unique sessions provide exhibiting companies the opportunity to present new research findings on products, detail products, conduct demonstrations, and highlight new products. Industry Product Theater Sessions are located in the Exhibit Hall Theater 1 (Booth 3347) and Theater 2 (Booth 2947).

These sessions are solely promotional and are not eligible for CME credit. You can also keep this link handy for the latest updates.

Friday, March 8

Treatment update: The First FDA-Approved Treatment for Molluscum Contagiosum
10:30-11:15 a.m.
Location: Theater 1, Booth 3347
Sponsor: Verrica Pharmaceuticals

See what's possible with Olumiant: 3-year data
12-12:45 p.m.
Location: Theater 1, Booth 3347
Sponsor: Lilly
This presentation includes a clinical overview of disease manifestations, clinical efficacy, and safety outputs from relevant pivotal trials. The facilitator will provide clinical insights and live Q&A following the presentation.

A Peer Perspective on an Oral Treatment Option for Adults with Moderate-to-Severe Plaque Psoriasis
1:30-2:15
Location: Theater 1, Booth 3347
Sponsor: Bristol Myers Squibb
This program describes the efficacy and safety profile of an oral product. You will learn more about the pivotal clinical trials, product function, and patient support services.

Comorbidities in Psoriasis from Psoriatic Arthritis to Obesity
11:15 a.m.-noon
Location: Theater 2, Booth 2947
Sponsor: Lilly
Join a panel of psoriasis experts for a discussion on important clinical considerations for comorbid conditions of psoriasis.

Clinical Case Discussion: A 62-Year-Old Female With Itchy Skin Lesions - Could it be PN?
12:45-1:30 p.m.
Location: Theater 2, Booth 2947
Sponsor: Sanofi and Regeneron

A New Approach to Skin Barrier Health
2:15-3 p.m.
Location: Theater 2, Booth 2947
Sponsor: RoC
RoC has developed a new approach to skin barrier health. SVP of Research & Development, Art Pellegrino, and board-certified Dermatologist, Dr. Muneeb Shah, will present the technology behind this innovation.

Saturday, March 9

Insights into Adbry® and a Patient Spotlight: An Update on the Efficacy and Safety of the Only Biologic Targeting IL-13 for Moderate-to-Severe Atopic Dermatitis
10:30-11:15 a.m.
Location: Theater 1, Booth 3347
Sponsor: LEO Pharmaceuticals
A patient-focused program where two leading dermatologists review the latest efficacy and safety data of Adbry® and feature a real-world patient to discuss insights into their treatment experience.

A Treatment Option for Patients With Uncontrolled Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
12-12:45 p.m.
Location: Theater 1, Booth 3347
Sponsor: Sanofi and Regenron

From Heterogeneity Comes New Insights: Exploring the Role of T Cells and OX40 in Atopic Dermatitis
11:15 a.m.-noon
Location: Theater 1, Booth 3347
Sponsor: Amgen
OX40 signaling can play a critical role in AD pathogenesis by driving T-cell-mediated effector and memory responses that orchestrate inflammation and disease chronicity.